Fidelity Investments’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1
Closed -$4 5553
2024
Q4
$4 Buy
+1
New +$5 ﹤0.01% 5493
2024
Q1
Sell
-2
Closed -$14 5587
2023
Q4
$14 Buy
+2
New +$13 ﹤0.01% 5266
2023
Q3
Sell
-1
Closed -$6 5438
2023
Q2
$6 Hold
1
﹤0.01% 5306
2023
Q1
$6 Sell
1
-1
-50% -$7 ﹤0.01% 5209
2022
Q4
$14 Buy
2
+1
+100% +$10 ﹤0.01% 5191
2022
Q3
$0 Hold
1
﹤0.01% 5216
2022
Q2
$0 Sell
1
-2
-67% -$30 ﹤0.01% 5282
2022
Q1
$0 Buy
+3
New +$65 ﹤0.01% 5291
2021
Q3
Sell
-3
Closed 4776
2021
Q2
$0 Buy
3
+2
+200% +$81 ﹤0.01% 4645
2021
Q1
$0 Buy
+1
New +$46 ﹤0.01% 4340

Other funds holding MSOS

Fidelity Investments's MSOS Position: Q1 2025 in Review

Fidelity Investments sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2025, closing a stake of 1 share — an estimated $4 sold.

Fidelity Investments first reported a position in MSOS in Q1 2021 and held it in 10 quarters. The position peaked at $14 in Q4 2023. 157 funds tracked by Wall St. Rank hold MSOS as of Q1 2025.

  • Fidelity Investments reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 1 AdvisorShares Pure US Cannabis ETF share in Q1 2025, an estimated $4.
  • Fidelity Investments first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2021 and held it in 10 quarters.
  • Fidelity Investments's AdvisorShares Pure US Cannabis ETF position peaked at $14 in Q4 2023.
  • 157 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.